A phase 2 trial of personalized cytotoxic therapy based on tumor immunohistochemistry in previously treated metastatic pancreatic cancer patients.
about
A phase 2 trial of personalized cytotoxic therapy based on tumor immunohistochemistry in previously treated metastatic pancreatic cancer patients.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
A phase 2 trial of personalize ...... ic pancreatic cancer patients.
@en
A phase 2 trial of personalize ...... ic pancreatic cancer patients.
@nl
type
label
A phase 2 trial of personalize ...... ic pancreatic cancer patients.
@en
A phase 2 trial of personalize ...... ic pancreatic cancer patients.
@nl
prefLabel
A phase 2 trial of personalize ...... ic pancreatic cancer patients.
@en
A phase 2 trial of personalize ...... ic pancreatic cancer patients.
@nl
P2093
P2860
P356
P1476
A phase 2 trial of personalize ...... ic pancreatic cancer patients.
@en
P2093
Anirban Maitra
Daniel D Von Hoff
Edward C Stites
Gayle Jameson
Glen J Weiss
Joanne Xiu
Manuel Hidalgo
Meraj Aziz
Michael T Barrett
Monica Fulk
P2860
P304
P356
10.21037/JGO.2017.09.05
P577
2017-12-01T00:00:00Z